Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03916588 · ClinicalTrials.gov registry record
Dementia Management With Interactive Technology
A clinical trial, sponsored by Ochsner Health System.
- Terminated
- Registry status
- 89
- Enrollment target
NCT03916588: Clinical Trial study, sponsored by Ochsner Health System.
NCT03916588 is a clinical trial that was terminated before completion, run by Ochsner Health System. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03916588 was terminated before completion, sponsored by Ochsner Health System.
- TERMINATED
- Registry status
- 89 participants
- Enrollment target
Study Summary
To investigate the efficacy of an individualized treatment plan delivered through remote technology along with enhanced staff training within a supervised memory unit on patient outcome, care quality, health care utilization/cost, and staff burden. Remote monitoring of activity data will also be explored.
Interventions
- BEHAVIORAL Individualized Care Plan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2018-08-16 |
| Est. Completion | 2020-12-31 |
Why NCT03916588 stopped before completion
NCT03916588 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Individualized Care Plan is the first listed.
NCT03916588 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03916588 about?
NCT03916588 is a clinical study titled "Dementia Management With Interactive Technology". To investigate the efficacy of an individualized treatment plan delivered through remote technology along with enhanced staff training within a supervised memory unit on patient outcome, care quality, health care utilization/cost, and staff burden. Remote monitoring of activity data will also be exp...
What is the current status of trial NCT03916588?
This trial is currently terminated. The enrollment target is 89 participants. The study started on 2018-08-16. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03916588?
The interventions under investigation include: Individualized Care Plan (BEHAVIORAL).
Who is sponsoring clinical trial NCT03916588?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI